I figured I would go ahead and post. With Rain being on vacation and myself being reluctant to keep on the rant, this forum becomes lifeless. I think BMOD did not expect having to deal with a sub-group of data and it may be interfering with its posting of the results. We are already breaking into the second half of the months and the company has not said anything. It is worrysome, analyzing this data should not have taken this long. If this would be a company with a number of formulas in its pipeline, well then you have some hedge, but BMOD's only lifeline is Cypath. They can easily come up with less than perfect results but say "hey is not a big deal, all we need to do is separate the cancerous from the pre-cancerous and everything will be fine" The only problem with that is that such event could take an entire year, not too mention that it would drive the price to the floor. Could be rewarding but also scary...matter of fact I should call them right now.